NIH-funded research R01 grant

Automated language analysis to detect Alzheimer’s and frontotemporal dementia in Latino and English-speaking adults

Official title: An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations

Funded at University of California, San Francisco · NIH-11553465 · Data updated 2026-11-12

A low-cost, computer-based language and speech analysis tool will help identify Alzheimer’s disease and frontotemporal dementia in Latino and English-speaking adults.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 15, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$445,998
NIH project number3R01AG075775-04S1
Project IDNIH-11553465 on NIH RePORTER

Who could benefit from this research

Could help

Adults (ages typically affected by AD/FTD) who are Spanish-speaking or English-speaking, including diverse socio-biological backgrounds and multilingual individuals.

Less likely to help

Some patients may not benefit if they do not have language-related markers detectable by speech analyses or do not access the study sites.

What this research studies

This project uses easy-to-collect speech samples to build a machine learning framework that can distinguish Alzheimer’s disease and frontotemporal dementia across diverse language and cultural backgrounds. It focuses on 2,740 participants including Spanish speakers from Latin America and English speakers in the US, and will examine how factors like bilingualism and brain profiles affect markers. The study aims to create robust, culturally valid ASLA measures that work across languages and socio-biological contexts without relying on expensive standard tests. By comparing new speech-based markers with traditional measures, it seeks to improve early detection and monitoring for Latino communities. The approach combines acoustic and linguistic data to generate scalable, low-cost diagnostics that could be used in real-world clinical or community settings.

Why it matters

Potential benefit: If successful, patients could receive earlier, more accessible detection and monitoring for AD and FTD through simple speech-based assessments.

How similar studies have gone: Previous studies show promise for speech-based markers, but this project emphasizes cross-language validity and large-scale diversity, which is novel.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Gorno Tempini, Maria Luisa — University of California, San Francisco
  • Study coordinator: Gorno Tempini, Maria Luisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.